Loading chat...

GA HB1332

Bill

Status

Introduced

2/17/2026

Primary Sponsor

David Clark

Click for details

Origin

House of Representatives

2025-2026 Regular Session

AI Summary

  • Healthcare providers receiving Georgia state funds must give preference to American manufactured pharmaceuticals when procuring prescription drugs for patient care, provided such drugs are reasonably available

  • "American manufactured pharmaceutical" is defined as a prescription drug manufactured, processed, and finished at a U.S. facility registered with the FDA; "substantially higher" cost is defined as greater than 20 percent

  • Exceptions allow providers to procure foreign-made drugs when American versions are unavailable, would jeopardize patient safety, are needed for emergencies or drug shortages, or cost more than 20 percent higher

  • Healthcare providers must document the basis for any exception and retain records for a minimum of three years; non-compliance may result in corrective action plans or loss of eligibility for state funds

  • The preference applies only to state fund expenditures and does not interfere with physician medical judgment, federal law, or federal procurement requirements

Legislative Description

Georgia Buy American Medicine Act; enact

Last Action

House Committee Favorably Reported By Substitute

3/3/2026

Committee Referrals

Health2/18/2026

Full Bill Text

No bill text available